Providence Clinical Research   Report issue

For profit Phase 2
Founded: North Hollywood CA United States (2012)

Organization Overview

First Clinical Trial
2012
NCT00814372
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Providence Clinical Research, North Hollywood, CA 91606 | Translational Research Group, Inc. dba Providence Clinical Research

Active Ingredients

Drugs in Phase 2 Trials (4)

arhalofenate (1 trial)

favipiravir (1 trial)

pioglitazone (actos) (1 trial)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Influenza, Human (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4